Krystal Biotech Inc (KRYS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

2100 WHARTON STREET PITTSBURGH, PA 15203

Krystal Biotech, Inc. operates as a biopharmaceutical company. The Company develops a proprietary gene therapy platform for the patients suffering from rare debilitating disorders. Krystal Biotech serves patients in the State of Pennsylvania.

Data as of 2020-09-12
Market Cap856.96 Million Shares Outstanding19.664 Million Avg 30-day Volume133.191 Thousand
P/E Ratio Dividend Yield EPS-1.24
Price/Sales Price cash flow ratio Price free cash flow ratio-29.1
Book Value15.75 Price to Tangible Book2.77 Alpha0.05
Short Interest Ratio % Short Interest to Float R-squared0.101581
BETA1.02868 52-week High/Low66.85 / 31.89 Stddev0.165495
View SEC Filings from KRYS instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 2 -50.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 110 90 22.22% 32 (2.09%) 26 (1.66%) 23.08%
13F shares: 14.113 Million 11.501 Million 22.7% 5.24 Million 4.748 Million 10.35%
% Ownership 71.78 66.2113 8.41% 26.6509 27.3348 -2.5%
New Positions: 30 13 130.77% 11 5 120.0%
Increased Positions 46 34 35.29% 10 10 0.0%
Closed Positions 10 14 -28.57% 5 6 -16.67%
Reduced Positions 22 29 -24.14% 9 7 28.57%
Total Calls 24.6 Thousand 0
Total Puts 26.502 Thousand 0
PUT/CALL Ratio 1.08
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding KRYS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KRYS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

50 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KRISHNAN SUMA CHIEF OPERATING OFFICER

  • Officer
  • Director
  • 10% Owner
3,834,688 2020-09-15 4

JANNEY DANIEL

  • Director
0 2020-06-30 1

ROSSI DINO A

  • Director
0 2020-06-30 1

GANGOLLI JULIAN S

  • Director
0 2020-06-30 1

KRISHNAN KRISH S PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
3,934,688 2020-05-15 3

CHIEN JENNIFER CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-01-31 2

ROMANO KATHRYN CHIEF ACCOUNTING OFFICER

  • Officer
0 2020-01-31 2

RILEY ANTONY A CHIEF FINANCIAL OFFICER

  • Officer
9,050 2019-11-19 1

NORBY R DOUGLAS

  • Director
0 2018-05-31 0

SUN PHARMA (NETHERLANDS) B.V.

  • 10% Owner
0 2017-09-19 0

GANORKAR KIRTI

  • Director
0 2017-09-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2020-09-17 18:35:05 -0400 2020-09-17 S 7,437 $46.63 d 1,837,190 direct yes -8.7028 0.0 1 -8.7028 2

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2020-09-17 18:35:05 -0400 2020-09-17 S 10,594 $46.09 d 1,844,627 direct yes -8.7028 0.0 1 -8.7028 2

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2020-09-17 18:35:05 -0400 2020-09-17 S 1,126 $47.29 d 1,836,064 direct yes -8.7028 0.0 1 -8.7028 2

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2020-09-17 18:35:05 -0400 2020-09-16 S 9,749 $46.24 d 1,860,363 direct yes -8.7028 0.0 1 -8.7028 2

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2020-09-17 18:35:05 -0400 2020-09-16 S 5,142 $46.85 d 1,855,221 direct yes -8.7028 0.0 1 -8.7028 2

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2020-09-17 18:35:05 -0400 2020-09-15 S 14,435 $46.21 d 1,871,629 direct yes -8.7028 0.0 1 -8.7028 2

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2020-09-17 18:35:05 -0400 2020-09-15 S 1,517 $47.15 d 1,870,112 direct yes -8.7028 0.0 1 -8.7028 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments